US Patent

US7872049 — Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate

Method of Use · Assigned to G Pohl Boskamp GmbH and Co KG · Expires 2029-03-12 · 3y remaining

Vulnerability score 80/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a pharmaceutical preparation containing glyceryl trinitrate that has improved storage stability due to the addition of a proton-absorbing substance.

USPTO Abstract

A pharmaceutical preparation containing the active substance glyceryl trinitrate having improved storage stability in a container. The improved storage stability is achieved by the addition of a proton-absorbing substance either as part of the preparation as placed into the container or applied to the surface of the preparation's storage container before the remaining components of the preparation are placed into the container. The preparation can preferably be filled into a plastic bottle having a spray pump.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-2223 — nitroglycerin

Patent Metadata

Patent number
US7872049
Jurisdiction
US
Classification
Method of Use
Expires
2029-03-12
Drug substance claim
No
Drug product claim
Yes
Assignee
G Pohl Boskamp GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.